The penetration of ofloxacin (OFLX) into prostatic tissue was examined on 11 patients with benign prostatic hypertrophy. OFLX was administered orally in a dose of 200 mg, three times one day before and twice on the day of operation. The blood sample was taken 30 minutes before operation and prostatic tissue specimens were collected during operation. The mean concentration of OFLX in prostatic tissue was 5.51 ± 1.79 "gIg (mean±SD) and 5.36±1.28 "g/ml in serum. Thc mean ratio of these concentrations was 1.06±0.31 (range 0.55~1.54). These findings indicate that OFLX will be valuable against bacterial prostatitis. Key words: Ofloxacin, Prostatic concentratio
<p align="LEFT">Chronic prostatitis is the most common urological disease in men aged 20 to 50 years...
Objective: To investigate the effectiveness of ciprofloxacin in the treatment of chronic bacterial p...
Objective: To investigate the effectiveness of ciprofloxacin in the treatment of chronic bacterial p...
For assessing plasma and tissue concentrations of norfloxacin after oral administration, twelve pati...
Background and Purpose: To compare the concentrations of two fluoroquinolones, ofloxacin (OFLX) and ...
The pharmacokinetics of ofloxacin were studied in six healthy volunteers following a 600 mg oral dos...
The choice of antimicrobial agents for treatment of prostatitis should be based on two factors: in v...
We devided infections following transurethral resection of the prostate (TUR-P) into postoperative a...
Fleroxacin is a new fluoroquinolone with a broad antibacterial spectrum and a serum half-life of abo...
Ten patients with prostatitis were administered with Enoxacin (ENX), and the changes in its concentr...
Objective To clarify the value of endotoxin concentrations in expressed prostatic secretions (EPS) ...
Twenty-nine patients were treated for recurrent chronic bacterial prostatitis by an injection of 2 G...
The safety and pharmacokinetics of ofloxacin in 48 healthy male volunteers were studied in a two-cen...
Prostatitis remains a challenging condition. The clinical features are often non-specific while the ...
Copyright © 2013 Bing-Juin Chiang et al. This is an open access article distributed under the Creati...
<p align="LEFT">Chronic prostatitis is the most common urological disease in men aged 20 to 50 years...
Objective: To investigate the effectiveness of ciprofloxacin in the treatment of chronic bacterial p...
Objective: To investigate the effectiveness of ciprofloxacin in the treatment of chronic bacterial p...
For assessing plasma and tissue concentrations of norfloxacin after oral administration, twelve pati...
Background and Purpose: To compare the concentrations of two fluoroquinolones, ofloxacin (OFLX) and ...
The pharmacokinetics of ofloxacin were studied in six healthy volunteers following a 600 mg oral dos...
The choice of antimicrobial agents for treatment of prostatitis should be based on two factors: in v...
We devided infections following transurethral resection of the prostate (TUR-P) into postoperative a...
Fleroxacin is a new fluoroquinolone with a broad antibacterial spectrum and a serum half-life of abo...
Ten patients with prostatitis were administered with Enoxacin (ENX), and the changes in its concentr...
Objective To clarify the value of endotoxin concentrations in expressed prostatic secretions (EPS) ...
Twenty-nine patients were treated for recurrent chronic bacterial prostatitis by an injection of 2 G...
The safety and pharmacokinetics of ofloxacin in 48 healthy male volunteers were studied in a two-cen...
Prostatitis remains a challenging condition. The clinical features are often non-specific while the ...
Copyright © 2013 Bing-Juin Chiang et al. This is an open access article distributed under the Creati...
<p align="LEFT">Chronic prostatitis is the most common urological disease in men aged 20 to 50 years...
Objective: To investigate the effectiveness of ciprofloxacin in the treatment of chronic bacterial p...
Objective: To investigate the effectiveness of ciprofloxacin in the treatment of chronic bacterial p...